Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies

Qiliang Cai; Yudong Wu; Zhanjun Guo; Rui Gong; Yang Tang; Kuo Yang; Xiaodong Li; Xuemei Guo; Yuanjie Niu; Yan Zhao

doi:10.18632/oncotarget.6061

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies

Qiliang Cai, Yudong Wu, Zhanjun Guo, Rui Gong, Yang Tang, Kuo Yang, Xiaodong Li, Xuemei Guo, Yuanjie Niu and Yan Zhao _

PDF | HTML | How to cite

Oncotarget. 2015; 6:37500-37510. https://doi.org/10.18632/oncotarget.6061

Metrics: PDF 1479 views | HTML 2358 views | ?

Abstract

Qiliang Cai1, Yudong Wu1, Zhanjun Guo1, Rui Gong2, Yang Tang1, Kuo Yang1, Xiaodong Li3, Xuemei Guo4, Yuanjie Niu1 and Yan Zhao5

1 Department of Urology, Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin, China

2 Pharmaceutical Department, the Second Hospital of Tianjin Medical University, Tianjin, China

3 Department of Radiotherapy, the Second Hospital of Tianjin Medical University, Tianjin,China

4 Library of Tianjin Medical University, Tianjin Medical University, Tianjin, China

5 Tianjin Institute of Infectious Disease, the Second Hospital of Tianjin Medical University, Tianjin, China

Correspondence to:

Yan Zhao, email:

Keywords: BLCA-4, diagnostic biomarker, bladder cancer, diagnosis, meta-analysis

Received: July 16, 2015 Accepted: September 23, 2015 Published: October 09, 2015

Abstract

Epidemiological studies have explored the diagnostic effect of urine BLCA-4 in bladder cancer. However, the results remain controversial. Therefore, we conducted this pooled analyses to determine the overall accuracy of urine BLCA-4 in bladder cancer. A comprehensive electronic and hand search was conducted for related literatures though several databases. QUADAS-2 was used to assess the quality of each included studies. Diagnostic parameters were calculated using Meta-Disc (version 1.4) and Stata (version 12.0) software. Nine published articles with 1,119 subjects were included. The summary estimates were: sensitivity 0.93 (95 % confidence interval [CI] = 0.90-0.95), specificity 0.97 (95% CI, 0.95-0.98), positive likelihood ratio 48.16 (95% CI, 11.77-197.01), negative likelihood ratio 0.08 (95% CI, 0.06-0.11), diagnostic odds ratio 534.03 (95% CI, 150.15-1899.31), and the AUC was 0.9607. In conclusion, urine BLCA-4 is a promising marker in diagnosing bladder cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6061

Publication Alerts

Research Papers:

Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies

Abstract